Expert summaries of myopia management evidence launched

The International Myopia Institute (IMI) has released the latest in a series of white papers in a special issue of Investigative Ophthalmology and Visual Science (IOVS).

“Year on year, there are a growing number of myopia management options available and it can be difficult for practising clinicians to keep pace with the evolving evidence base. The white papers bring together leading experts around the world to provide consensus and summarise the latest evidence to make it easily accessible and readily available to implement in practice,” said program director Dr Nina Tahhan.

The papers are freely available online. The IMI is committed to developing and disseminating the latest evidence-based research for all to benefit, she added.

The latest white papers highlight:
• Evidence around the onset, progression, and management of myopia in less typical young adult and paediatric populations.
• The role of the choroid in eye growth control and myopia management.
• A detailed anatomical paper on non-pathological ocular tissue changes observed in moderate to high myopia.
• The results of an international survey of practitioners on myopia management attitudes and strategies in clinical practice.
• A digest which updates the latest evidence from topics covered in previous editions.

The first two series of IMI white papers, from 2019 and 2021, outlined consensus and clinical management guidance for myopia development and management.

Professor James Wolffsohn, IMI chief scientific officer said, “We have brought together the leading experts in myopia research from across the globe once again to ensure that clinicians have the latest information on myopia control to provide the best service to their patients, to highlight areas where more research is required and to guide the ophthalmic industry in the development of products needed for the future.”

The 2023 IMI White Papers can be accessed freely here. Clinical summaries will be released soon.

The IMI 2019 White Paper can be accessed freely here and 2021 here. The IMI was founded by Australian not-for-profit, the Brien Holden Vision Institute (BHVI).